Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-03-10Clinical Trial Update: Interest of Indocyanine Green in Neoplastic Prostatic Tissue [Phase 3]
A Phase 3 trial evaluating indocyanine green in neoplastic prostatic tissue has been withdrawn. The trial was sponsored by Centre Hospitalie…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery [Phase 2]
A Phase 2 trial evaluated finasteride in men with stage II prostate cancer undergoing surgery, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer
This completed trial evaluates a urinary exosome gene signature for diagnosing prostate cancer in men presenting with suspected disease, aim…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
This completed clinical trial collected blood samples from older men at high risk of developing prostate cancer and from healthy male partic…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Safety Evaluation of ExAblate MRgFUS for Prostate Cancer [Phase 1]
Phase 1 safety evaluation of ExAblate MRgFUS for prostate cancer has completed. The document provides a status update on the study.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer [Phase 3]
Phase 3 trial comparing androgen ablation therapy with versus without chemotherapy in patients with metastatic hormone-sensitive prostate ca…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 3]
A Phase 3 study comparing two radiation therapy regimens in men with stage II or stage III prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Micro-RNA Expression Profiles in High Risk Prostate Cancer
Clinical trial evaluating micro-RNA expression profiles in high-risk prostate cancer (NCT01220427) has been terminated.
-
FDA label_change · 2016-02-29FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals. The supplemental action updates the …
-
FDA approval · 2016-02-29FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) submitted by URONOVA Pharmaceuticals.
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
This completed decision-impact study evaluates how the DECIPHER genomic classifier influences treatment recommendations by radiation oncolog…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Multi-site Decision Impact Study for Decipher
A multi-site decision impact study involving the Decipher genomic classifier by GenomeDx Biosciences for prostate cancer has completed.
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
This clinical trial update describes a study investigating genomic, proteomic, and dosimetric determinants of late toxicity after three-dime…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Blood Test to Measure DNA Damage in Blood
A clinical trial evaluating a blood test to measure DNA damage in blood for prostate cancer has been terminated.
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: Development of a Therapeutic Education Program for Patients Operated for Prostate Cancer [NA]
A completed clinical trial evaluating a therapeutic education program for patients who have undergone prostate cancer surgery.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation [NA]
This completed trial assesses the use of high-field magnetic resonance spectroscopy imaging to follow up patients with prostate cancer after…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation
A completed clinical trial update evaluating the prevalence of osteoporosis in patients with advanced prostate cancer who are treated with h…
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer [NA]
A completed clinical trial evaluated the use of 3T magnetic resonance spectroscopy to help localize prostate cancer and correlated imaging f…
-
CLINICAL_TRIALS research · 2016-02-24Clinical Trial Update: Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy
Completed clinical trial update analyzing serum PSA dynamics after radiotherapy for prostate cancer using mathematical modeling.
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects
This clinical trial update describes the completion of Herlev Hospital's database tracking sexual side effects after radiation therapy in me…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers
This clinical trial update reports measurements of the biomarker 11-dh-TXB2 in blood and urine from prostate cancer patients and healthy vol…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) [Phase 2]
Phase 2 clinical trial evaluating the combination of thalidomide and Doxil in patients with androgen-independent prostate cancer; results ha…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer [Phase 2]
Phase 2 trial of pazopanib hydrochloride after leuprolide or goserelin in relapsed prostate cancer has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer [NA]
The clinical trial evaluating functional MRI to guide high-throughput curietherapy (brachytherapy) planning in prostate cancer has completed…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Erectile Dysfunction/Prostate/RT/Androgen [Phase 2]
Phase 2 clinical trial update related to prostate cancer; the study has completed.